RTTNews | May 14, 2021 08:14AM EDT

08:13 Friday, May 14, 2021 (RTTNews) - Outlook Therapeutics Q2 Net Loss Attributable $13.1 Mln Or $0.09/Shr Vs Loss $17.5 Mln Or $0.36/Shr Year-ago

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved